Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...
Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...
DEAR MAYO CLINIC: My dad was diagnosed with cardiac amyloidosis shortly after his 70th birthday. It's difficult to pronounce let alone understand. What is cardiac amyloidosis? Am I at risk if it is ...
Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a buildup ...
This transcript has been edited for clarity. Michelle M. Kittleson, MD: Welcome to Medscape InDiscussion: Heart Failure. I'm your host, Dr Michelle Kittleson. This is the seventh episode of our ...
Health on MSN
Could Your Carpal Tunnel Symptoms Indicate a Hidden Heart Condition Called ATTR? What You Need To Know
Carpal tunnel syndrome can be an early sign of transthyretin amyloidosis (ATTR), though most people with carpal tunnel won't develop ATTR.
Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...
Alnylam Canada ULC is pleased to announce that Health Canada has issued a Notice of Compliance (NOC) authorizing AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy in adult patients with ...
New Digital Health Community Delivers Rare Disease Resources and Peer Support for ATTR Amyloidosis Patients and Caregivers PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Health Union, the leading digital ...
Multiple myeloma and AL amyloidosis are conditions linked to plasma cells in the bone marrow. Multiple myeloma (MM) is a cancer affecting the plasma cells, which are mostly in the bone marrow. MM ...
HELIOS-B is a global, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy and safety of AMVUTTRA (R) in adult patients with wtATTR or hATTR amyloidosis with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results